Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - NET CHANGE IN CASH
Net Change in Cash ITCI - Intra-Cellular Therapies, Inc.
-848 K
LAST VALUE
-1.30%
2 YEAR CAGR
-0.97%
5 YEAR CAGR
-0.43%
10 YEAR CAGR